Literature DB >> 27396912

Methylation of LOXL1 Promoter by DNMT3A in Aged Human Skin Fibroblasts.

Léa Moulin1, Valérie Cenizo2, Alengo Nyamay Antu1, Valérie André2, Sabine Pain2, Pascal Sommer1, Romain Debret1.   

Abstract

Lysyl oxidase-like 1 (LOXL1) is an amino-oxidase involved in maturation of elastic fibers. Its downregulation has been associated with elastic fibers repair loss in aging aorta, lung, ligament, and skin. Several evidences of LOXL1 epigenetic silencing by promoter methylation were reported in cancer and cutis laxa syndrome. We hypothesized that this mechanism could be implicated in skin aging process, as far as elastic fibers are also concerned. Anti-DNMT3A chromatin immunoprecipitation was conducted with nuclear extracts from skin fibroblasts isolated from young and elderly individuals, and showed a higher level of DNMT3A protein binding to the LOXL1 promoter in older cells concomitantly to the decrease of LOXL1 mRNA expression and the increase of LOXL1 promoter methylation. Using luciferase reporter assay driven by LOXL1 promoter in HEK293 cells, we demonstrated that LOXL1 transcriptional activity was dramatically reduced when a recombinant DNMT3A was concomitantly overexpressed. LOXL1 promoter transcriptional activity was restored in the presence of a broad-spectrum inhibitor of DNMT activity, 5-aza-2'-deoxycytidine. Finally, to assess whether the interplay between DNMT3A and LOXL1 promoter could be targeted to increase LOXL1 mRNA expression level, an Origanum majorana extract was selected among 43 plant extracts as a new inhibitor of human DNMT3A activity to restore LOXL1 secretion without cytotoxicity in aged skin fibroblasts.

Entities:  

Keywords:  DNA-methyltransferase; fibroblasts; lysyl oxidase-like 1; skin aging

Mesh:

Substances:

Year:  2016        PMID: 27396912     DOI: 10.1089/rej.2016.1832

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  1 in total

1.  Senescent fibroblasts drive ageing pigmentation: ​A potential therapeutic target for senile lentigo.

Authors:  Jung Eun Yoon; Yeongeun Kim; Soohyun Kwon; Misun Kim; Young Hwa Kim; Jang-Hee Kim; Tae Jun Park; Hee Young Kang
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.